Home example 2 - Pharmamarketeer

wet- en regelgeving

Regeneron’s COVID-19 antibody cocktail scores FDA emergency approval

COVID-19 antibody cocktail
Drug approved to treat high-risk patients with mild to moderate COVID-19.

PMLiVE

3 x gelezen

marketing

AI-modellen worden meer ingezet en steeds geavanceerder

Binnen de data-driven marketingsector worden modellen steeds geavanceerder. Dat blijkt uit de DDMA AI Maturity Test 2022. Van de organisaties die AI inzetten geeft maar liefst 92% van de participanten aan meer gebruik...

fonkonline.nl

3 x gelezen

overig

5 brands share their content marketing process

It’s a hazard of the job for content marketers. When you read or see a piece of high-quality content, you wonder how it got created. You ask yourself, “What does this company do to create great content? Is it great for...

contentmarketinginstitute.com

3 x gelezen

wet- en regelgeving

FDA approves Pfizer’s drug for advanced breast cancer

The U.S. Food and Drug Administration said on Tuesday it approved Pfizer Inc’s drug for an advanced form of breast cancer tied to an inherited gene mutation.

Reuters Health

3 x gelezen

farma-industrie

Pfizer and Novartis partner up to develop combo therapies for NASH

Pfizer and Novartis are set to team up in a non-exclusive partnership aimed at the clinical development of one or more combo therapies for the treatment of non-alcoholic steatohepatitis (NASH). Under the partnership...

InPharm.com

3 x gelezen

wet- en regelgeving

Keytruda Gets FDA Approval for Hepatocellular Carcinoma

The approval was based on data from the KEYNOTE-224 study, a single-arm trial in patients with HCC who had disease progression on or after sorafenib or were intolerant to sorafenib; had measurable disease; and Child...

Monthly Prescribing Reference (MPR): Drug News

3 x gelezen

onderzoek

Phase 3 failure of asthma therapy sends Vectura’s ailing shares falling

Vectura has announced it is terminating development of its severe asthma therapy VR475, an inhaled formulation of the corticosteroid budesonide, after it failed in Phase 3 trials to demonstrate a significant impact on...

InPharm.com

3 x gelezen

farma-industrie

Roche’s Hemlibra stakes claim to be haemophilia market leader

Hemlibra was widely expected to become the dominant therapeutic for treating haemophilia patients and its latest clinical trial results only cements its prospects in the field.

Pharmafile

3 x gelezen

farma-industrie

J&J stock tumbles after Reuters reports it hid asbestos in talc

After a series of ups and downs in defense of its flagship Johnson’s Baby Powder, Johnson & Johnson hit renewed scrutiny Friday as Reuters reported the drugmaker knew for decades its powder contained cancer-causing...

FiercePharma

3 x gelezen

overig

‘Europese regels nodig over transparantie banden zorg en farma’

Het openbaar maken van financiële banden tussen zorgverleners en de farmaceutische industrie in Europa kan beter. Ook in Nederland is er nog onvoldoende transparantie, concluderen onderzoekers van universiteiten in...

Skipr

3 x gelezen

Latest articles

Regeneron’s COVID-19 antibody cocktail scores FDA emergency approval

AI-modellen worden meer ingezet en steeds geavanceerder

5 brands share their content marketing process

FDA approves Pfizer’s drug for advanced breast cancer

Pfizer and Novartis partner up to develop combo therapies for NASH

Keytruda Gets FDA Approval for Hepatocellular Carcinoma

Phase 3 failure of asthma therapy sends Vectura’s ailing shares falling

Roche’s Hemlibra stakes claim to be haemophilia market leader

J&J stock tumbles after Reuters reports it hid asbestos in talc

‘Europese regels nodig over transparantie banden zorg en farma’

Wekelijkse highlights per e-mail

Algemene informatie